Related references
Note: Only part of the references are listed.Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab
A. Egeberg et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Exposure to Infliximab During Pregnancy: Post-Marketing Experience
Anja Geldhof et al.
DRUG SAFETY (2020)
Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database
R. B. Warren et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis
Uma Mahadevan et al.
INFLAMMATORY BOWEL DISEASES (2018)
Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data
Maria Hoeltzenbein et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
Evaluation and treatment of recurrent pregnancy loss: a committee opinion
FERTILITY AND STERILITY (2012)
Share Paper
